Clinical Trial Update: The Effects of a CONCOR Smartphone Application [NA]

View source ↗

Summary

Clinical trial NCT02599857 evaluating the CONCOR smartphone application for congenital heart disease and related arrhythmia/heart failure indications has been w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia
• Congenital Heart Disease
• Heart Failure

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Congenital Heart Disease, Smartphone Application | NA | Status: WITHDRAWN